94 related articles for article (PubMed ID: 6138045)
1. Pharmacology of 4-(2-hydroxy-3-[(1-methyl-3-phenylpropyl)-amino]propoxy)benzeneacetamide (KF-4317).
Kubo K; Nakamura J; Karasawa A; Shuto K; Nakamizo N
Arzneimittelforschung; 1983; 33(7):926-31. PubMed ID: 6138045
[TBL] [Abstract][Full Text] [Related]
2. A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug.
Brittain RT; Levy GP
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):681-4. PubMed ID: 10948
[TBL] [Abstract][Full Text] [Related]
3. Extremely long-acting antihypertensive effects of KF-4317, a alpha- and beta 1-adrenoceptor blocker.
Kubo K; Ikeda J; Nakamura J; Nakamizo N
Arch Int Pharmacodyn Ther; 1985 Sep; 277(1):140-60. PubMed ID: 2865934
[TBL] [Abstract][Full Text] [Related]
4. Adrenoceptor blocking effects of arotinolol, a new combined alpha- and beta-adrenoceptor blocking agent.
Miyagishi A; Nakahara H; Hara Y
Arch Int Pharmacodyn Ther; 1984 Oct; 271(2):249-62. PubMed ID: 6210068
[TBL] [Abstract][Full Text] [Related]
5. Actions of 4-(2-hydroxy-3-[(1-methyl-3-phenylpropyl)amino]propoxy) benzeneacetamide (KF4317) and labetalol on alpha- and beta-adrenoceptors.
Takayanagi I; Koike K; Konno F; Hiruta T; Kusunoki M; Sato T; Toyoda J; Kizawa Y
Gen Pharmacol; 1986; 17(6):651-3. PubMed ID: 3028902
[TBL] [Abstract][Full Text] [Related]
6. The alpha- and beta-adrenoceptor blocking potencies of labetalol and its individual stereoisomers in anaesthetized dogs and in isolated tissues.
Brittain RT; Drew GM; Levy GP
Br J Pharmacol; 1982 Sep; 77(1):105-14. PubMed ID: 6127131
[TBL] [Abstract][Full Text] [Related]
7. (+/-)-1-[[2-(3,4-Dimethoxphenyl)ethyl]amino]-3-(3-methylphenoxy)-2- propanol hydrochloride (bevantolol, NC-1400) as a beta 1-selective adrenoceptor blocker with alpha 1-adrenoceptor blocking activity.
Takayanagi I; Kizawa Y; Iwasaki S; Nakagoshi A
Gen Pharmacol; 1987; 18(1):87-9. PubMed ID: 2881837
[TBL] [Abstract][Full Text] [Related]
8. Vasoactive and beta-adrenoceptor blocking properties of 3,4-dihydro-8-(2-hydroxy-3-isopropylamino) propoxy-3-nitroxy-2H-1-benzopyran (K-351), a new antihypertensive agent.
Uchida Y; Nakamura M; Shimizu S; Shirasawa Y; Fujii M
Arch Int Pharmacodyn Ther; 1983 Mar; 262(1):132-49. PubMed ID: 6135395
[TBL] [Abstract][Full Text] [Related]
9. [Atenolol, its cardioselective property for adrenergic beta-receptor blocking action and effect on the cardiac function (author's transl)].
Kanno M; Nakaya H; Hattori Y; Izumi T; Nishimura T; Sakai K; Abiko Y
Nihon Yakurigaku Zasshi; 1980 Oct; 76(7):621-32. PubMed ID: 6111522
[TBL] [Abstract][Full Text] [Related]
10. Derivatives related to betaxolol with alpha- and beta-adrenergic activities.
Leclerc G; Decker N; Schwartz J
Arzneimittelforschung; 1985; 35(9):1357-67. PubMed ID: 2867769
[TBL] [Abstract][Full Text] [Related]
11. Pharmacology of AH 5158; a drug which blocks both - and -adrenoceptors.
Farmer JB; Kennedy I; Levy GP; Marshall RJ
Br J Pharmacol; 1972 Aug; 45(4):660-75. PubMed ID: 4404413
[TBL] [Abstract][Full Text] [Related]
12. [Alpha- and beta-adrenoceptor blocking actions of labetalol and effects on the myocardial function, coronary circulation and myocardial energy metabolism thereof (author's transl)].
Katano Y; Takeda K; Nakagawa Y; Hashimoto T; Nakazawa M; Tsukada T; Otorii T; Imai S
Nihon Yakurigaku Zasshi; 1978 Oct; 74(7):819-32. PubMed ID: 33880
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological profile of a new beta-adrenoceptor blocker, 4-[3-(tert-butylamino)-2-hydroxypropoxy]-N-methylisocarbostyril hydrochloride (N-696).
Nakagawa Y; Sugai T; Chin WP; Shibuya T; Hashimoto K; Imai S
Arzneimittelforschung; 1984; 34(2):194-9. PubMed ID: 6144313
[TBL] [Abstract][Full Text] [Related]
14. Adrenoceptor-blocking activity and cardiohemodynamic effects of carvedilol in animals.
Kawada T; Ishibashi T; Nakazawa M; Satoh S; Imai S
J Cardiovasc Pharmacol; 1990 Jul; 16(1):147-53. PubMed ID: 1696657
[TBL] [Abstract][Full Text] [Related]
15. Alpha and beta adrenoceptor blocking properties of labetalol and its R,R-isomer, SCH 19927.
Sybertz EJ; Sabin CS; Pula KK; Vliet GV; Glennon J; Gold EH; Baum T
J Pharmacol Exp Ther; 1981 Aug; 218(2):435-43. PubMed ID: 6114171
[TBL] [Abstract][Full Text] [Related]
16. Evidence for adrenergic and tachykinin activity in venom of the stonefish (Synanceja trachynis).
Hopkins BJ; Hodgson WC; Sutherland SK
Toxicon; 1996 May; 34(5):541-54. PubMed ID: 8783449
[TBL] [Abstract][Full Text] [Related]
17. Pharmacology of 2-amino-1,4-dihydro-4-(2-[4-[4-(2-methoxyphenyl)-1- piperazinyl]butylsulfinyl]phenyl)-6-methyl-5-nitro-3-pyridine carboxylic acid methyl ester (XB513), a novel calcium agonist with alpha-1 adrenergic receptor antagonistic.
Wong PC; Aldrich PE; Chiu AT; Earl RA; Hart SD; Johnson AL; Ma P; McCall DE; Price WA; Smith RD
J Pharmacol Exp Ther; 1993 Jun; 265(3):1088-95. PubMed ID: 8099616
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of the new alpha- and beta-adrenergic antagonist 1-[1-(2-benzodioxanylmethyl)-4-piperidyl]amino-3-(1-naphthoxy)-2- propanol.
Mauleón D; Antúnez S; Rosell G
Farmaco; 1989 Nov; 44(11):1109-17. PubMed ID: 2577151
[TBL] [Abstract][Full Text] [Related]
19. Enantiomers of 8-(3-tert-butylamino-2-hydroxypropoxy)-3,4-dihydro-3-oxo-2H- (1,4)benzothiazine: racemic resolution, chiral synthesis and biological activity.
Schiaffella F; Fringuelli R; Cecchetti V; Fravolini A; Angeli P; Marucci G
Farmaco; 1990 Dec; 45(12):1299-307. PubMed ID: 1982489
[TBL] [Abstract][Full Text] [Related]
20. [On the pharmacology of the beta-receptor blocker penbutolol (author's transl)].
Kaiser J; Härtfelder G; Lindner E; Schölkens B
Arzneimittelforschung; 1980; 30(3):420-7. PubMed ID: 6992788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
